摘要
目的 观察CT导引下聚桂醇硬化治疗肝、肾、盆腔巨大囊肿的临床疗效。方法 选取2014年9月—2015年1月连云港市东方医院收治的肝、肾、盆腔巨大囊肿患者16例,均予以CT导引下聚桂醇硬化治疗,并观察患者预后。结果 16例患者均一次穿刺成功,术后无出血、发热、感染等并发症,术后1-2个月复查CT示残余囊肿腔均缩小至Ⅲ级。结论 CT导引下聚桂醇硬化治疗肝、肾、盆腔巨大囊肿的临床疗效确切,适用于对无水乙醇耐受性差、高龄及体质虚弱的患者,可提高患者的生活质量。
Objective To explore the effect of lauromacrogol sclerotherapy in treating hepatic, renal and pelvic cysts under CT guidance. Methods A total of 16 patients with hepatic, renal and pelvic cysts were selected in the Eastern Hospital of Lianyungang from September 2014 to January 2015 , all be under CT guidance assembling cinnamyl alcohol hardening treatment, prognosis of the patients were observed. Results The 16 patients were one - time successful puncture, postoperative complications such as bleeding, fever, infection, 1 ？2 months after review CT residual cyst cavity were narrowed to IE Rank. Conclusion Lauromacrogol sclerotherapy has certain clinical effect in treating hepatic, renal and pelvic cysts under CT guidance, suitable for anhydrous ethanol tolerance is poor elderly and frail patients, can improve the life quality of patients.
出处
《中国全科医学》
CAS
CSCD
北大核心
2016年第B12期386-388,共3页
Chinese General Practice
关键词
囊肿
盆腔肿瘤
聚桂醇
治疗结果
Cysts
Pelvic neoplasms； Lauromacrogol ； Treatment outcome
